Pulmonary and meningeal cryptococcosis caused by Cryptococcus gattii in an immunocompetent patient: a case report.

Authors

  • Amanda Farao Lima Silva Hospital Universitário da Universidade Federal de Juiz de Fora/HU Brasil, Juiz de Fora, Minas Gerais, Brasil.
  • Laura Lavorato Soldati Hospital Universitário da Universidade Federal de Juiz de Fora/HU Brasil, Juiz de Fora, Minas Gerais, Brasil.
  • Lucas Machado Moreira Fundação Osvaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brasil.
  • Cristiane Marcos Soares Dias Ferreira Hospital Universitário da Universidade Federal de Juiz de Fora/HU Brasil, Juiz de Fora, Minas Gerais, Brasil.
  • Patricia Guedes Departamento de Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Juiz de Fora, Minas Gerais, Brasil. https://orcid.org/0000-0002-0795-6422

DOI:

https://doi.org/10.34019/1982-8047.2026.v52.52532

Keywords:

Criptococose, Cryptococcus gattii, Meningite criptocócica, imunocompetência

Abstract

Introduction: Cryptococcosis is a systemic mycosis associated with high morbidity and mortality, traditionally linked to immunocompromised individuals, particularly people living with HIV. However, infections caused by Cryptococcus gattii have increasingly been described in immunocompetent individuals, often presenting with atypical clinical features that may hinder early diagnosis. Objective: To describe a case of pulmonary and meningeal cryptococcosis in an immunocompetent patient, highlighting diagnostic challenges and clinical evolution. Case report: A 58-year-old immunocompetent male, living in an urban area, with a history of occasional activities involving cleaning of warehouses and water tanks, presented with chest pain, fever, and dyspnea, later progressing to severe headache. Imaging studies revealed an expansive pulmonary lesion with pseudotumoral features, initially suggestive of neoplasia. Microbiological investigation, including cerebrospinal fluid analysis and fungal culture, confirmed pulmonary cryptococcosis associated with cryptococcal meningitis, with identification of Cryptococcus gattii. The patient received antifungal therapy according to guidelines, showing initial microbiological response; however, clinical deterioration ensued, requiring surgical intervention and resulting in a fatal outcome. Conclusion: This case highlights that cryptococcosis caused by C. gattii should be considered in the differential diagnosis of pseudotumoral pulmonary lesions in immunocompetent patients, as it may present with severe progression despite appropriate treatment, underscoring the importance of early diagnosis.

 

Downloads

Download data is not yet available.

Author Biography

Patricia Guedes, Departamento de Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Juiz de Fora, Minas Gerais, Brasil.

Farmacêutica - Bioquímica

Mestrado em Saúde - UFJF

Doutorado em Saúde - UFJF

Profa. SUPREMA

References

1. Meya DB, Williamson PR. Cryptococcal Disease in Diverse Hosts. N Engl J Med. 2024; 390(17):1597-1610. DOI: 10.1056/NEJMra2311057.

2. Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, et al. The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis. mSphere. 2017; 2(1):e00357-16. DOI: 10.1128/mSphere.00357-16.

3. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50(3):291-322. DOI: 10.1086/649858.

4. Herkert PF, Hagen F, Pinheiro RL, Muro MD, Meis JF, Queiroz-Telles F. Ecoepidemiology of Cryptococcus gattii in Developing Countries. J Fungi (Basel). 2017; 3(4):62. DOI: 10.3390/jof3040062.

5. Pappas PG. Cryptococcal infections in non-HIV-infected patients. [Internet]Trans Am Clin Climatol Assoc. 2013[citado em 2026 abr. 10]; 124:61-79. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC3715903/.

6. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Guia de Vigilância em Saúde [Internet]. 5ª ed. Brasília: Ministério da Saúde; 2021[citado em 2026 mai. 28]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigilancia/guia-de-vigilancia-em-saude-5a-edicao-revisada-e-atualizada-2022/view.

7. World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action [Internet]. Geneva: World Health Organization; 2022 [citado em 2026 abr. 10]. Disponível em: https://www.who.int/publications/i/item/9789240060241.

8. Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications. Clin Infect Dis 2023; 76: 764-70. DOI: 10.1093/cid/ciac675.

9. Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022; 22(12):1748-55. DOI: 10.1016/S1473-3099(22)00499-6.

10. Lee YC, Wang JT, Sun HY, Chen YC. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect. 2011; 44(5):338-45. DOI: 10.1016/j.jmii.2010.08.011.

11. Zhao H, Zhou M, Zheng Q, Zhu M, Yang Z, Hu C, et al. Clinical features and Outcomes of Cryptococcemia patients with and without HIV infection. Mycoses. 2021; 64(6):656-667. DOI: 10.1111/myc.13261.

12. Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic Agents of Cryptococcosis. Cold Spring Harb Perspect Med. 2014; 4(7):a019760. DOI: 10.1101/cshperspect.a019760.

13. Chen SC, Meyer W, Sorrell TC. Cryptococcus gattii Infections. Clin Microbiol Rev. 2014; 27(4):980-1024. DOI: 10.1128/CMR.00126-13.

14. World Health Organization. WHO guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children [Internet]; 2018 [citado em 2026 abr. 12]. Geneva: World Health Organization; 2022. Disponível em: https://www.who.int/publications/i/item/9789241550277.

15. Xu L, Yu J, Zheng B, Su F, Yang Z, Guo Y, et al. HIV Infection Does Not Increase 10-Week Mortality of Chinese Cryptococcal Meningitis Patients. AIDS Res Hum Retroviruses. 2020; 36(9):734-741. DOI: 10.1089/AID.2020.0001.

16. Brizendine KD, Baddley JW, Pappas PG. Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status. PLoS One. 2013; 8(3):e60431. DOI: 10.1371/journal.pone.0060431.

Published

2026-10-08

How to Cite

1.
Silva AFL, Soldati LL, Moreira LM, Ferreira CMSD, Patricia Guedes. Pulmonary and meningeal cryptococcosis caused by Cryptococcus gattii in an immunocompetent patient: a case report. HU Rev [Internet]. 2026 Oct. 8 [cited 2026 Oct. 8];52:1-5. Available from: https://periodicos.ufjf.br/index.php/hurevista/article/view/52532

Issue

Section

Relato de Caso

Similar Articles

You may also start an advanced similarity search for this article.